Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (431-440 of 752) with videos related to

Pageof 76
Sort By:
JACC. Cardiovascular Interventions|January 22, 2011
Drug-eluting introducer sheath prevents local peripheral complications: pre-clinical evaluation of nitric oxide-coated sheathRayyan Hemetsberger, Aniko Posa, Serdar Farhan, et al.
Thrombosis and Haemostasis|May 26, 2012
Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?Paul A Gurbel, Matthew T Roe, Joseph A Jakubowski, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 30, 2008
Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registryAlois Suessenbacher, Jakob Doerler, Hannes Alber, et al.
American Heart Journal|November 18, 2005
Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studiesJochen Gödicke, Marcus Flather, Marko Noc, et al.
ESC Heart Failure|May 16, 2023
Short-term toll-like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarctionMax Lenz, Attila Kiss, Patrick Haider, et al.
Journal of the American College of Cardiology|October 18, 2003
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trialMarc Cohen, Gian Franco Gensini, Frans Maritz, et al.
Biomedicines|January 30, 2021
Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque ProgressionMax Lenz, Christoph Kaun, Konstantin A Krychtiuk, et al.
Heart (British Cardiac Society)|February 19, 2015
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolongedAnthony H Gershlick, Cynthia M Westerhout, Paul W Armstrong, et al.
FEBS Letters|May 30, 2006
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxiaPhilipp J Hohensinner, Christoph Kaun, Kathrin Rychli, et al.
Blood|August 5, 2009
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammationStefan P Kastl, Walter S Speidl, Katharina M Katsaros, et al.
Pageof 76

Showing results (431-440 of 752) with videos related to

Sort By:
Pageof 76
JACC. Cardiovascular Interventions|January 22, 2011
Drug-eluting introducer sheath prevents local peripheral complications: pre-clinical evaluation of nitric oxide-coated sheathRayyan Hemetsberger, Aniko Posa, Serdar Farhan, et al.
Thrombosis and Haemostasis|May 26, 2012
Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?Paul A Gurbel, Matthew T Roe, Joseph A Jakubowski, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 30, 2008
Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registryAlois Suessenbacher, Jakob Doerler, Hannes Alber, et al.
American Heart Journal|November 18, 2005
Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studiesJochen Gödicke, Marcus Flather, Marko Noc, et al.
ESC Heart Failure|May 16, 2023
Short-term toll-like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarctionMax Lenz, Attila Kiss, Patrick Haider, et al.
Journal of the American College of Cardiology|October 18, 2003
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trialMarc Cohen, Gian Franco Gensini, Frans Maritz, et al.
Biomedicines|January 30, 2021
Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque ProgressionMax Lenz, Christoph Kaun, Konstantin A Krychtiuk, et al.
Heart (British Cardiac Society)|February 19, 2015
Impact of a pharmacoinvasive strategy when delays to primary PCI are prolongedAnthony H Gershlick, Cynthia M Westerhout, Paul W Armstrong, et al.
FEBS Letters|May 30, 2006
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxiaPhilipp J Hohensinner, Christoph Kaun, Kathrin Rychli, et al.
Blood|August 5, 2009
Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammationStefan P Kastl, Walter S Speidl, Katharina M Katsaros, et al.
Pageof 76